To elucidate the molecular mechanisms underlying SETDB1 relocalization in DMD myotubes, we first tested if SETDB1 nuclear translocation in response to TGFβ was dependent on SMAD3, which is the effector translocating to the nucleus in response to TGFβ. This evidence concerns the gene TGFB1 and Duchenne muscular dystrophy.